Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries
Sang Gune K. Yoo, Grace S. Chung, Silver K. Bahendeka, Abla M. Sibai, Albertino Damasceno, Farshad Farzadfar, Peter Rohloff, Corine Houehanou, Bolormaa Norov, Khem B. Karki, Mohammadreza Azangou-Khyavy, Maja E. Marcus, Krishna K. Aryal, Luisa C.C. Brant, Michaela Theilmann, Renata Cífková, Nuno Lunet, Mongal S. Gurung, Joseph Kibachio Mwangi, Joao MartinsRosa Haghshenas, Lela Sturua, Sebastian Vollmer, Till Bärnighausen, Rifat Atun, Jeremy B. Sussman, Kavita Singh, Sahar Saeedi Moghaddam, David Guwatudde, Pascal Geldsetzer, Jennifer Manne-Goehler, Mark D. Huffman, Justine I. Davies, David Flood
Dive into the research topics of 'Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries'. Together they form a unique fingerprint.